BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting

  Glaukos Corporation announced that its technologies will be featured in various scientific programming at the European Society of Cataract and Refractive Surgeons Annual Meeting, being held October 8-11, 2021, in Amsterdam, Netherlands.

  October 7, 2021

   · 

  7 min read
• Drug Development

  Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal

  Miromatrix Medical Inc., a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced it has successfully completed the first ever heterotopic implant of its bioengineered liver transplant into a large animal.

  October 7, 2021

   · 

  7 min read
• Press Releases

  Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent

  Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, announced that the European Patent Office has issued a new patent, No. 3352584, to the company’s TriLink BioTechnologies subsidiary.

  October 7, 2021

   · 

  4 min read
• Biotech Beach

  Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

  Amgen and Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases, announced a strategic collaboration to advance neuroscience discovery, development and commercialization.

  October 7, 2021

   · 

  10 min read
• Stallergenes Greer Launches CORAP (Community for Research in Allergic Patients) Research Programme

  Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy, announced the launch of CORAP.

  October 7, 2021

   · 

  1 min read
• Silence Therapeutics to Host R&D Day on October 21, 2021

  Silence Therapeutics to Host R&D Day on October 21, 2021

  October 7, 2021

   · 

  3 min read
• Drug Development

  Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints

  Management to host webcast and conference call today at 8:30 a.m. ET to present the topline results

  October 7, 2021

   · 

  10 min read
• Genetown

  Cerevel Therapeutics Hosts Virtual R&D Event to Review CVL-871 in Dementia-Related Apathy and Provide Update on CVL-231 for the Treatment of Schizophrenia

  Cerevel Therapeutics will host a virtual R&D event today from 10:00 to 11:30 a.m. ET.

  October 7, 2021

   · 

  6 min read
• Business

  Tris Pharma® Hires Seasoned Business Development Executive

  Tris Pharma, Inc. today announced that Anthony Amato has joined the company as Executive Vice President Business Development – Generics Division.

  October 7, 2021

   · 

  2 min read
• Drug Development

  Ocuphire Announces Publications Featuring the Ref-1 Protein, a Transcription Factor Regulator, as a Novel Therapeutic Target for the Treatment of Neovascular Retinal Diseases

  Ocuphire’s Phase 2 ZETA-1Trial Evaluating APX3330 (an Oral Ref-1 Inhibitor) for the Treatment of Diabetic Retinopathy is Currently Recruiting with Data Expected in 2022

  October 7, 2021

   · 

  9 min read